Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-04 · accession 0001510281-24-000319 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-06-05 | 2024-06-04+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.61 | +59.4K | 3.38M | +2% | +$809.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-04 | P | A | 33,357 | $13.50 | 3,354,025 | I - | — | — | |
| 2 | Common | Common Stock | 2024-06-05 | P | A | 26,083 | $13.76 | 3,380,108 | I - | — | — |